Henrik Schmidt Email & Phone Number

Oberzent, He, De

Odense, South Denmark, Denmark

Non-exec. Director – focus on Commercial Strategy• Supporting the CEO and leadership team in his startup through a tremendous growth spurt on the commercial and organizational side – company revenue grew from 1mEUR to 30mEUR from 2019 to 2020 and organization from 10 to 140 FTEs

Baden-Württemberg, Germany

• Lead restructuring of commercial operations leading CMT product sales EMEA from brand to customer focus. Met or exceeded Qtr. 2020 sales goals despite Cov19. 35 FTE sales team ~35m USD sales.• As GM for six European Operating Sites led the successful global alignment for operations and R&D – Biochrom, CMA, Panlab, Harvard Apparatus, Multichannel Systems, HEKA and Hugo Sachs. C. 150 FTE.• With realignment of sales transferred half of the book of business to new global distribution team I completed my position growth cycle

Düsseldorf Area, Germany

• Lead all commercial aspects of launching the new Medtrum medical devices and software solutions in the T1 diabetes field• Created novel market access strategies with great success in Germany and Scandinavia – exceeding new customer growth expectations • Designed and created complete sales and fulfillment infrastructure• Drove legal entities incorporation and recruiting first level sales leadership in main markets (DE, NL, UK, F, AT, FI, DK etc.)• Designed and initiating first marketing and medical studies• Grew sales organization from 4->40 FTE by end 2020

Mannheim, Germany

Reporting to Head of Global Operations, Diabetes Care•Defining and leading the work stream covering all commercial aspects of the operations unit activities in spinning Roche Diabetes Care out into a separate business unit. Leading a multi-disciplines team accountable for all regulatory, supply chain and commercial related issues of changing to a new legal manufacturer while mitigating any supply disruption for 2.700 product variants, sold in 194 countries via 21 new local legal entities •Project successfully closed and handed over to Commercial Operations and Regulatory Affairs with neither supply interruptions nor significant scrap costs.

Mannheim, Germany

Reporting to Global Head of Diabetes CareHead of Roche global insulin pump business, responsible for IDS LifeCycle:• Global IDS P&L ~250mCHF p.a. • Integration of Indianapolis (USA), Burgdorf (CH), Yoqneam (IL) and Mannheim IDS activities in one global site • Close and phase out of Burgdorf and Israel sites• Establishment of a dedicated IDS team in Mannheim covering R&D, product marketing and product management (~35 FTE global and ~100 FTE in R&D)• Development and roll-out of new customer focused segment strategy for IDS

Indianapolis, Usa

Reporting to Head of North America, Diabetes CareResponsible for the Roche North America Insulin Pump business:• P/L North America IDS• Reorganization and realignment of both internal and customer facing organization in US and Canada (~130 FTE)• Setting up and implementing innovative go to market strategy - resulting in double digit growth in new customer acquisition

Burgdorf, Switzerland

Reporting to Head of Global Portfolio Group, Diabetes CareResponsible for the Insulin Delivery Systems product portfolio planning, R&D projects management and global product management (~30 FTE team):• Integration of IDS business into Accu-Chek• Establishment of world class pump team• Initiated and led the development and launch of next generation pump (Accu-Chek Combo)

Mannheim, Germany

Reporting to Head of Global Portfolio Group, Diabetes CareResponsible for the global Integrated BgM product portfolio planning, R&D projects management, global product management (~15 FTE):• Creation of new integrated BgM segment• Grew business from 50mCHT to 550mCHF• Launched several new global products (Compact, Go, Integra etc.)• Kicked of development of next generation products (Mobile)

Copenhagen Area, Denmark

Reporting to head of innovationResponsible for screening and assessement of new ventures. leading creation of new ventures as CEO• Led establishment of three ventures and lead them as CEO during the establishment phase• Co-lead screening and developing further 7 ventures

Copenhagen Area, Denmark

Reporting to CEO Responsible for• Daily administration of the business on behalf of the Germany based CEO• Business development and licensing activities (several licenses sold)• Local lead of due-dilligence and sale of PNAD to DAKO in 1999

Oslo Area, Norway

Oslo Area, Norway

Mba

Bba

High School